In the United States, three monoclonal antibody therapies
targeting SARS-CoV-2 are available for the treatment of
non-hospitalized adults (≥18 years of age) and children (≥12 years
of age weighing at least 40 kg) with mild to moderate COVID-19 and
specific risk factors for severe disease. This monclonal antibody
therapy refers to the 3 vaccines (Moderna, Pfizer and J&J)
currently available in the USA.
True or false
In the United States, three monoclonal antibody therapies targeting SARS-CoV-2 are available for the treatment of non-ho
-
answerhappygod
- Site Admin
- Posts: 899604
- Joined: Mon Aug 02, 2021 8:13 am
In the United States, three monoclonal antibody therapies targeting SARS-CoV-2 are available for the treatment of non-ho
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!